• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 October

Post Archive by Month

Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.

In Dermatology
by ClinOwl
October 22, 2020

There are no well-defined clinical factors to predict the risk of occult invasion in melanoma of the lentigo maligna type (LM) prior to complete histopathologic analysis.To evaluate whether clinical size …

Trends in Mortality and Cause-specific Mortality among patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada.

In Dermatology
by ClinOwl
October 22, 2020

There is limited information about mortality rates among patients with psoriasis and psoriatic arthritis (PsA) in North America and their change over the past two decades.To compare all-cause and cause-specific …

View Post

SONG-HD Fatigue Reliable, Valid Scale for Fatigue in Hemodialysis

In HealthDay News
by Healthday
October 22, 2020

SONG HD Fatigue measure was internally consistent and stable over a one-week period

View Post

U.S. COVID-19 Vaccine Trial Enrolls 30,000

In HealthDay News
by Healthday
October 22, 2020

Moderna says it is on track to apply for FDA approval to market the vaccine in early December

View Post

CDC: Number of COVID-19 Deaths May Be Underreported

In HealthDay News
by Healthday
October 22, 2020

Only two-thirds of the nearly 300,000 excess deaths in 2020 are attributed to COVID-19

View Post

Flavan-3-ol Intake Appears to Lower Systolic Blood Pressure

In HealthDay News
by Healthday
October 22, 2020

Reduction comparable to adherence to Mediterranean diet or moderate reduction in salt

View Post

CDC Broadens Definition of ‘Close Contact’ in Tracing COVID-19 Infections

In HealthDay News
by Healthday
October 22, 2020

Change will likely have biggest impact in group settings where people are in repeated contact with others

American Academy of Pediatrics, Oct. 2-5

In HealthDay News
by Healthday
October 22, 2020

The American Academy of Pediatrics National Conference The annual meeting of the American Academy of Pediatrics was held virtually this year from Oct. 2 to 5 and attracted participants from …

View Post

Skin Breaks Drop With Prolonged AL/CVL Use in Neonates

In HealthDay News
by Healthday
October 22, 2020

Larger thalamic volumes seen with prolonged arterial line, central venous line use and fewer skin breaks

View Post

Cytokines Not at ‘Storm’ Levels in Those With Severe COVID-19

In HealthDay News
by Healthday
October 22, 2020

Levels in severely, critically ill COVID-19 patients much lower than in other inflammatory syndromes

  • Page 7 of 39
  • ←
  • 1
  • ...
  • 6
  • 7
  • 8
  • ...
  • 39
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep   Nov »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer